PPT Slide

Objective:

Design:

Dosage

Schedule:

Population:

Primary Endpoint:

Determine effect on plaque size as determined by intravascular ultrasound (IVUS)

Double-blind, randomized, placebo-controlled, multiple-dose, efficacy and safety study

2 dose groups with weekly infusions for 4 weeks for a maximum of 5 doses

50 patients with acute coronary syndromes

Effect on plaque size of a coronary artery

ETC-216-002 Study

Previous slide

Next slide

Back to first slide

View graphic version